Transparency data
Voluntary scheme aggregate net sales and payment information: February 2022
Information on how the 2019 voluntary scheme for branded medicines pricing and access is controlling spend on branded medicines in the NHS.
Documents
Details
This document sets out the聽NHS鈥檚 quarterly aggregate net sales and payment information on pharmaceuticals for November 2021.
罢丑别听2019 voluntary scheme for branded medicines pricing and access聽is an agreement between the Department for Health and Social Care,聽NHS聽England and the Association of the British Pharmaceutical Industry that aims to:
- improve patient access to medicines by getting the best value and most effective medicines into use more quickly
- keep the branded medicine bill affordable for the聽NHS聽through a cap in growth of branded sales
- support innovation and a successful life sciences industry in the聽UK
Updates to this page
Published 14 March 2022